Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Restoring STING expression in soft tissue sarcoma increases activation and function of tumor-infiltrating lymphocytes.

Cancer immunology, immunotherapy : CII·2026
Same author

The prognostic value of tumour budding for survival in stage II and III colorectal cancer: a systematic review and meta-analysis.

Histopathology·2026
Same author

CAR-T cells targeting fibroblast activation protein eliminate pathological fibroblasts and preserve cardiac function in a Duchenne Muscular Dystrophy murine model.

Stem cell research & therapy·2026
Same author

Neutral sphingomyelinases restrict natural killer cells activity against lung cancer.

Cancer immunology, immunotherapy : CII·2026
Same author

Epigenetic remodeling in sarcoma promotes T-cell infiltration via modulation of the Hippo pathway.

Journal for immunotherapy of cancer·2026
Same author

Impact of Microporous Layer Composition on the Water Content in the Membrane Electrode Assembly of Polymer Electrolyte Fuel Cells.

ACS applied materials & interfaces·2026
Same journal

The lncRNA-m6A axis in cancer: a bidirectional regulatory network in tumor progression and therapeutic resistance.

Journal of translational medicine·2026
Same journal

Repurposing cepharanthine as a radiosensitizer in esophageal squamous cell carcinoma through dual metabolic intervention and direct targeting of p70s6K.

Journal of translational medicine·2026
Same journal

Cellular crosstalk and signaling networks in the rheumatoid arthritis synovial microenvironment.

Journal of translational medicine·2026
Same journal

Pilot spatial transcriptomics of dental pulpitis suggests immune-fibroblast profiling linked to reversibility.

Journal of translational medicine·2026
Same journal

Beyond semen analysis: in men with normal semen parameters telomere attrition and oxidative imbalance distinguish those fertile from those with infertility.

Journal of translational medicine·2026
Same journal

Dual-block HER2 assessment reveals clinically relevant intratumoral heterogeneity in gynecologic cancers: a single-center landscape analysis.

Journal of translational medicine·2026
See all related articles

Related Experiment Video

Updated: May 18, 2026

Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
06:05

Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Published on: June 2, 2023

Cancer classification using the Immunoscore: a worldwide task force.

Jérôme Galon1, Franck Pagès, Francesco M Marincola

  • 1INSERM, U872, Laboratory of Integrative Cancer Immunology, Paris, F-75006, France. jerome.galon@crc.jussieu.fr

Journal of Translational Medicine
|October 5, 2012
PubMed
Summary
This summary is machine-generated.

The Immunoscore, an assessment of the immune system

More Related Videos

Multiplex Immunohistochemical Analysis of the Spatial Immune Cell Landscape of the Tumor Microenvironment
06:32

Multiplex Immunohistochemical Analysis of the Spatial Immune Cell Landscape of the Tumor Microenvironment

Published on: August 18, 2023

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Related Experiment Videos

Last Updated: May 18, 2026

Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
06:05

Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Published on: June 2, 2023

Multiplex Immunohistochemical Analysis of the Spatial Immune Cell Landscape of the Tumor Microenvironment
06:32

Multiplex Immunohistochemical Analysis of the Spatial Immune Cell Landscape of the Tumor Microenvironment

Published on: August 18, 2023

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Area of Science:

  • Oncology
  • Immunology
  • Pathology

Background:

  • Traditional cancer staging (AJCC/UICC-TNM) has limitations in predicting clinical outcome and therapy response.
  • The host immune system plays a critical role in controlling tumor progression.
  • Existing staging lacks prognostic information beyond tumor burden and spread.

Purpose of the Study:

  • To highlight the prognostic and predictive value of immunological biomarkers in cancer.
  • To advocate for the integration of the Immunoscore into traditional cancer classification.
  • To address the need for harmonization in quantitative immunohistochemistry assays.

Main Methods:

  • Review of accumulating data from large human cancer cohorts.
  • Analysis of the impact of immune-classification on prognosis.
  • Discussion of an international task force initiative for Immunoscore validation.

Main Results:

  • Immune-classification demonstrates significant prognostic value, potentially augmenting the AJCC/UICC TNM-classification.
  • The Immunoscore can provide essential prognostic and predictive information.
  • Immunophenotyping of tumors offers crucial novel prognostic insights.

Conclusions:

  • Incorporating the Immunoscore into cancer classification (TNM-I) will enhance clinical decision-making and patient treatment stratification.
  • Assay harmonization is urgently required for the routine clinical application of the Immunoscore.
  • The validation of the Immunoscore may lead to its implementation as a new standard in cancer classification.